Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase
Importantly, the study confirmed that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo, with no treatment-related serious adverse events or study withdrawals occurring
Furthermore, in a phase 2 clinical trial addressing a patient group with type 2 diabetes and overweight/obesity, after 32 weeks of treatment, the cagrisema 2.4 mg group exhibited a more significant average weight loss compared to the cagrilintide 2.4 mg group or the group using semaglutide 2.4 mg alone, with reductions of 15.6%, 8.1%, and 5.1%, respectively
A dietician consult, frequent lifestyle management counseling throughout the trial, and dietary advice regarding health food choices, calorie restriction, and macronutrient composition
Better immune support: Higher levels of active glutathione help support immune cell function and assist in detoxification pathways
Regular B12 (methylcobalamin or cyanocobalamin) is the vitamin alone
